LILIUM NV (LILM)

NL0015000F41 - Common Stock

0.052  -0.03 (-36.97%)

After market: 0.0564 +0 (+8.46%)

Fundamental Rating

1

Taking everything into account, LILM scores 1 out of 10 in our fundamental rating. LILM was compared to 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LILM have multiple concerns. LILM has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

LILM had negative earnings in the past year.
In the past year LILM has reported a negative cash flow from operations.
In the past 5 years LILM always reported negative net income.
LILM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

LILM has a worse Return On Assets (-124.74%) than 93.94% of its industry peers.
LILM has a worse Return On Equity (-1050.03%) than 83.33% of its industry peers.
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROIC N/A
ROA(3y)-102.55%
ROA(5y)-98.21%
ROE(3y)-431.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LILM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, LILM has more shares outstanding
LILM has a better debt/assets ratio than last year.

2.2 Solvency

LILM has an Altman-Z score of -7.40. This is a bad value and indicates that LILM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -7.40, LILM is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
LILM has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
LILM has a better Debt to Equity ratio (0.22) than 74.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -7.4
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LILM has a Current Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.84, LILM is doing worse than 87.88% of the companies in the same industry.
LILM has a Quick Ratio of 0.84. This is a bad value and indicates that LILM is not financially healthy enough and could expect problems in meeting its short term obligations.
LILM has a worse Quick ratio (0.84) than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84

1

3. Growth

3.1 Past

LILM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.14%, which is quite good.
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.80% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.65%
EPS Next 2Y13.68%
EPS Next 3Y9.58%
EPS Next 5Y22.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILM. In the last year negative earnings were reported.
Also next year LILM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y9.58%

0

5. Dividend

5.1 Amount

No dividends for LILM!.
Industry RankSector Rank
Dividend Yield N/A

LILIUM NV

NASDAQ:LILM (11/5/2024, 8:00:02 PM)

After market: 0.0564 +0 (+8.46%)

0.052

-0.03 (-36.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap32.90M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.74%
ROE -1050.03%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y23.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y